tiprankstipranks
Trending News
More News >
Hyloris Pharmaceuticals SA (DE:52U)
:52U
Germany Market

Hyloris Pharmaceuticals SA (52U) Income Statement

Compare
7 Followers

Hyloris Pharmaceuticals SA Income Statement

Last quarter (Q4 2024), Hyloris Pharmaceuticals SA's total revenue was €2.70M, an increase of 76.88% from the same quarter last year. In Q4, Hyloris Pharmaceuticals SA's net income was €-1.43M. See Hyloris Pharmaceuticals SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 10.04M€ 2.09M€ 2.95M€ 3.10M€ 175.00K
Gross Profit
€ 9.81M€ 1.99M€ 2.86M€ 2.99M€ 30.00K
Operating Expenses
€ 16.95M€ 17.99M€ 13.37M€ 13.34M€ 5.61M
Depreciation and Amortization
€ 1.23M€ 348.00K€ 196.00K€ 114.00K€ 101.00K
EBITDA
€ -4.85M€ -14.98M€ -11.43M€ -10.78M€ -6.17M
Operating Income
€ -7.13M€ -15.99M€ -11.64M€ -4.94M€ -7.03M
Other Income/Expenses
€ 788.00K€ 613.00K€ -263.00K€ -741.00K€ -120.00K
Pretax Income
€ -6.34M€ -15.38M€ -11.90M€ -11.28M€ -7.14M
Net Income
€ -6.34M€ -15.38M€ -11.91M€ -11.58M€ -7.15M
Per Share Metrics
Basic EPS
€ -0.22€ -0.55€ -0.44€ -0.45€ -0.28
Diluted EPS
€ -0.22€ -0.55€ -0.44€ -0.45€ -0.28
Weighted Average Shares Outstanding
29.04M 28.00M 27.20M 25.83M 25.83M
Weighted Average Shares Outstanding (Diluted)
29.04M 28.00M 27.20M 25.83M 25.83M
Currency in EUR

Hyloris Pharmaceuticals SA Earnings and Revenue History